Thursday, September 07, 2017 10:15 PM ET
Radius Health (RDUS) sees Significant Insider buy Extending Trend of purchases over Last Quarter
There was noteworthy buying activity in Radius Health shares by an insider today, as revealed in a form 4 document filed with the SEC. One insider — Biotech Growth N V, 10% Owner — purchased 50,000 shares in the company having a market value of approximately $1,837,625. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 210,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 260,000 shares and have averaged 130,000 shares per transaction over this time period.
Insider buy/sell trading at Radius Health is higher than the 266 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 308 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Radius Health insiders was also higher. Within the peer group there were 7,884,069 shares purchased and 14,315,135 shares sold with company insiders selling 20,880 shares on average.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.